title: Treatment options for metastatic melanoma in solid organ transplant recipients.
authors.affiliation: Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Thuzar M
authors.initials: TM
authors.lastname: Shin
authors.affiliation: Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Tara
authors.initials: T
authors.lastname: Gangadhar
authors.affiliation: Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Miller
keywords: CTLA, cytotoxic T-lymphocyte–associated protein 4; FDA, US Food and Drug Administration; IFN-α, interferon alfa; MAPK, mitogen-activated protein kinase; PD-1, programmed death-1; SOTRs, solid organ transplant recipients; immunosuppression; metastatic melanoma; organ transplant; systemic therapy